AN ACT INCREASING THE RATE OF THE CREDIT REFUND VALUE FOR CERTAIN EXPENDITURES BY BIOTECHNOLOGY COMPANIES.
To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.
Introduced by:
Finance, Revenue and Bonding CommitteeNew today | 2-4 days old | 5 days & older |
Text of Bill | |
File No. 718 [doc] | |
FIN Joint Favorable [doc] | |
Raised Bill [doc] |
Committee Actions | |
FIN Joint Fav. Rpt | |
FIN Vote Tally Sheet (Joint Favorable) |
Fiscal Notes | |
Fiscal Note For File Copy 718 |
Bill Analyses | |
Bill Analysis For File Copy 718 |
Co-sponsors for Amendment LCO:
Bill History
Date | Action Taken | ||
---|---|---|---|
5/4/2023 | (LCO) | File Number 718 | |
5/4/2023 | House Calendar Number 476 | ||
5/4/2023 | Favorable Report, Tabled for the Calendar, House | ||
5/4/2023 | (LCO) | Reported Out of Legislative Commissioners' Office | |
4/28/2023 | (LCO) | Referred to Office of Legislative Research and Office of Fiscal Analysis 05/03/23 5:00 PM | |
4/20/2023 | (LCO) | Filed with Legislative Commissioners' Office | |
4/19/2023 | (FIN) | Joint Favorable | |
4/10/2023 | Public Hearing 04/14 | ||
4/6/2023 | Referred to Joint Committee on Finance, Revenue and Bonding |
Co-sponsors of HB-6932
Sen. Joan V. Hartley, 15th Dist.
NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.